Biomarkers in molecular medicine: cancer detection and diagnosis
In spite of advances in diagnostics and therapeutics, cancer remains the second leading cause of death in the U.S. Successful cancer treatment depends not only on better therapies but also on improved methods to assess an individual's risk of developing cancer and to detect cancers at early sta...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2005-04-01
|
| Series: | BioTechniques |
| Online Access: | https://www.future-science.com/doi/10.2144/05384SU04 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850152725031944192 |
|---|---|
| author | Padma Maruvada Wendy Wang Paul D. Wagner Sudhir Srivastava |
| author_facet | Padma Maruvada Wendy Wang Paul D. Wagner Sudhir Srivastava |
| author_sort | Padma Maruvada |
| collection | DOAJ |
| description | In spite of advances in diagnostics and therapeutics, cancer remains the second leading cause of death in the U.S. Successful cancer treatment depends not only on better therapies but also on improved methods to assess an individual's risk of developing cancer and to detect cancers at early stages when they can be more effectively treated. Current cancer diagnostic imaging methods are labor-intensive and expensive, especially for screening large asymptomatic populations. Effective screening strategies depend on methods that are noninvasive and detect cancers in their early stages of development. There is increasing interest and enthusiasm in molecular markers as tools for cancer detection and prognosis. It is hoped that newly discovered cancer biomarkers and advances in high-throughput technologies would revolutionize cancer therapies by improving cancer risk assessment, early detection, diagnosis, prognosis, and monitoring therapeutic response. These biomarkers will be used either as stand-alone tests or to complement existing imaging methods. |
| format | Article |
| id | doaj-art-6aeb85a4d4f5410698c163a07eaab4ba |
| institution | OA Journals |
| issn | 0736-6205 1940-9818 |
| language | English |
| publishDate | 2005-04-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | BioTechniques |
| spelling | doaj-art-6aeb85a4d4f5410698c163a07eaab4ba2025-08-20T02:25:54ZengTaylor & Francis GroupBioTechniques0736-62051940-98182005-04-01384SS9S1510.2144/05384SU04Biomarkers in molecular medicine: cancer detection and diagnosisPadma Maruvada0Wendy Wang1Paul D. Wagner2Sudhir Srivastava31Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USAIn spite of advances in diagnostics and therapeutics, cancer remains the second leading cause of death in the U.S. Successful cancer treatment depends not only on better therapies but also on improved methods to assess an individual's risk of developing cancer and to detect cancers at early stages when they can be more effectively treated. Current cancer diagnostic imaging methods are labor-intensive and expensive, especially for screening large asymptomatic populations. Effective screening strategies depend on methods that are noninvasive and detect cancers in their early stages of development. There is increasing interest and enthusiasm in molecular markers as tools for cancer detection and prognosis. It is hoped that newly discovered cancer biomarkers and advances in high-throughput technologies would revolutionize cancer therapies by improving cancer risk assessment, early detection, diagnosis, prognosis, and monitoring therapeutic response. These biomarkers will be used either as stand-alone tests or to complement existing imaging methods.https://www.future-science.com/doi/10.2144/05384SU04 |
| spellingShingle | Padma Maruvada Wendy Wang Paul D. Wagner Sudhir Srivastava Biomarkers in molecular medicine: cancer detection and diagnosis BioTechniques |
| title | Biomarkers in molecular medicine: cancer detection and diagnosis |
| title_full | Biomarkers in molecular medicine: cancer detection and diagnosis |
| title_fullStr | Biomarkers in molecular medicine: cancer detection and diagnosis |
| title_full_unstemmed | Biomarkers in molecular medicine: cancer detection and diagnosis |
| title_short | Biomarkers in molecular medicine: cancer detection and diagnosis |
| title_sort | biomarkers in molecular medicine cancer detection and diagnosis |
| url | https://www.future-science.com/doi/10.2144/05384SU04 |
| work_keys_str_mv | AT padmamaruvada biomarkersinmolecularmedicinecancerdetectionanddiagnosis AT wendywang biomarkersinmolecularmedicinecancerdetectionanddiagnosis AT pauldwagner biomarkersinmolecularmedicinecancerdetectionanddiagnosis AT sudhirsrivastava biomarkersinmolecularmedicinecancerdetectionanddiagnosis |